Onconetix subsidiary adds Proteomedix co-founder to its board
Go back to Onconetix subsidiary adds Proteomedix co-founder to its board| Oncology Med, Inc. (NASDAQ: ONCO) | Delayed: 0.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.71 | 52 Week High | $0.00 | |||
| Open | $0.71 | 52 Week Low | $0.00 | |||
| Day High | $0.71 | P/E | N/A | |||
| Day Low | $0.71 | EPS | $0.00 | |||
| Volume | 21,804 | |||||
